| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $98.9M | -13.4% | +4.7% |
| SG&A Expense | $15.4M | -11.8% | -22.0% |
| Pre-tax Income | -$109.1M | +13.4% | +1.7% |
| Income Tax | $1.6M | +161.3% | +921.1% |
| Net Income | -$110.6M | +12.5% | +0.4% |
| EPS (Basic) | -$0.61 | +16.4% | +19.7% |
| EPS (Diluted) | -$0.61 | +16.4% | +19.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $994.5M | +90.6% | +165.4% |
| Accounts Receivable | $1.6M | -16.6% | -26.1% |
| Current Assets | $1.04B | +81.8% | +152.8% |
| Total Assets | $1.05B | +80.5% | +150.0% |
| Current Liabilities | $66.3M | +4.7% | -3.0% |
| Total Liabilities | $66.3M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$312.3M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $592.1M | — | — |
| Free Cash Flow | -$312.3M | — | — |
| -3.0% |
| Stockholders' Equity | $986.1M | +89.7% | +179.7% |